Latest filing published 29 Jun 2016 for Cartesian Therapeutics, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +42.0%Entry US$419.70 · Close at T+365 US$595.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
TAS Partners, LLC: trading record in brief
This profile gathers the share dealings of TAS Partners, LLC in Cartesian Therapeutics, Inc. We count 3 filings, every one of them for a trade on 27 June 2016.
On the market, this insider has only ever bought: 1 purchase, €9.0M in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The record was last updated on 29 June 2016 with a transaction in Cartesian Therapeutics, Inc. The clock since the last published purchase (29 June 2016) now reads 3,785 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to TAS Partners, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 506,015 shares0Common StockSEC:0001104659-16-130145:0
- 425,874 shares0Common StockSEC:0001104659-16-130145:1
- 710,000 shares@ US$14.00100.0% of flowCommon StockSEC:0001104659-16-130145:2Canonical exit: 25 Sept 2016 (T+90)
3 of 3 declarations
